{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:00:14Z","timestamp":1793289614872,"version":"4.5.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"8. Self-funded scientific research project of the Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine","award":["8. Self-funded scientific research project of the Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine"],"award-info":[{"award-number":["8. Self-funded scientific research project of the Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine"]}]},{"name":"6. Guangxi Zhuang Autonomous Region Engineering Research Center for the Development and Application of Snake-Based Anticancer Medicines","award":["Guangxi Development and Reform Commission High-Tech Letter (2023) No. 2727"],"award-info":[{"award-number":["Guangxi Development and Reform Commission High-Tech Letter (2023) No. 2727"]}]},{"name":"7. Guangxi Key Laboratory for the Prevention and Treatment of Regionally Prevalent Cancers Using Traditional Chinese Medicine","award":["Guangxi Traditional Chinese Medicine Science and Education Development [2023] No. 9"],"award-info":[{"award-number":["Guangxi Traditional Chinese Medicine Science and Education Development [2023] No. 9"]}]},{"name":"1. Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under Grant","award":["No. 2024GXNSFBA010165"],"award-info":[{"award-number":["No. 2024GXNSFBA010165"]}]},{"name":"2. The first batch of inclusive support policy projects for young talents in the autonomous region.","award":["No.2024-20"],"award-info":[{"award-number":["No.2024-20"]}]},{"name":"3. This research was supported by Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital","award":["No.2023-9"],"award-info":[{"award-number":["No.2023-9"]}]},{"name":"4. Youth Fund of Guangxi Medical University","award":["No. GXMUYSF202445"],"award-info":[{"award-number":["No. GXMUYSF202445"]}]},{"name":"5. Excellent Doctoral Research Start up Fund","award":["No.2023-1"],"award-info":[{"award-number":["No.2023-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01917-7","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T03:46:38Z","timestamp":1765511198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global burden of ovarian cancer attributable to high BMI, 1990\u20132021: spatiotemporal trends, risk factors, frontier analysis, and projections to 2036 based on GBD 2021 study"],"prefix":"10.1186","volume":"19","author":[{"given":"Jiujie","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12978-025-02013-1","volume":"22","author":"Y Gao","year":"2025","unstructured":"Gao Y, Wang X, Wang Q, Jiang L, Wu C, Guo Y, et al. Rising global burden of common gynecological diseases in women of childbearing age from 1990 to 2021: an update from the global burden of disease study 2021. Reprod Health. 2025;22:57. https:\/\/doi.org\/10.1186\/s12978-025-02013-1.","journal-title":"Reprod Health"},{"key":"1917_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1158\/1940-6207.CAPR-19-0184","volume":"13","author":"CV Trinidad","year":"2020","unstructured":"Trinidad CV, Tetlow AL, Bantis LE, Godwin AK. Reducing ovarian cancer mortality through early detection: approaches using Circulating biomarkers. Cancer Prev Res. 2020;13:241\u201352. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-19-0184.","journal-title":"Cancer Prev Res"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"100204","DOI":"10.1016\/j.clinsp.2023.100204","volume":"78","author":"B Gutic","year":"2023","unstructured":"Gutic B, Bozanovic T, Mandic A, Dugalic S, Todorovic J, Dugalic MG, et al. Preliminary outcomes of five-year survival for ovarian malignancies in profiled Serbian oncology centre. Clinics. 2023;78:100204. https:\/\/doi.org\/10.1016\/j.clinsp.2023.100204.","journal-title":"Clinics"},{"key":"1917_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.7150\/ijbs.86303","volume":"20","author":"M Wu","year":"2024","unstructured":"Wu M, Xie J, Xing Y, Zhang L, Chen H, Tang B, et al. Selectively targeting BCL6 using a small molecule inhibitor is a potential therapeutic strategy for ovarian cancer. Int J Biol Sci. 2024;20:486\u2013501. https:\/\/doi.org\/10.7150\/ijbs.86303.","journal-title":"Int J Biol Sci"},{"key":"1917_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s00432-025-06277-9","volume":"151","author":"Y Ren","year":"2025","unstructured":"Ren Y, Xu R, Wang Y, Su L, Su J. Global, regional, and National burden of ovarian cancer in women aged 45\u2009+\u2009from 1990 to 2021 and projections for 2050: A systematic analysis based on the 2021 global burden of disease study. J Cancer Res Clin Oncol. 2025;151:225. https:\/\/doi.org\/10.1007\/s00432-025-06277-9.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1917_CR6","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.34172\/ija.2024.e19","volume":"2","author":"S Safiri","year":"2024","unstructured":"Safiri S, Sorkhabi AD, Aletaha R, Hamidi S, Asghari KM, Sarkesh A, et al. Obesity: global Epidemiology, Trends, risk Factors, and clinical aspects. Int J Aging. 2024;2:e19. https:\/\/doi.org\/10.34172\/ija.2024.e19.","journal-title":"Int J Aging"},{"key":"1917_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3390\/biomedicines12030604","volume":"12","author":"B Kim","year":"2024","unstructured":"Kim B, Jung J. Impact of obesity and lysosomal dysfunction on chemoresistance in ovarian cancer. Biomedicines. 2024;12:604. https:\/\/doi.org\/10.3390\/biomedicines12030604.","journal-title":"Biomedicines"},{"key":"1917_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/nu17030556","volume":"17","author":"SA Paschou","year":"2025","unstructured":"Paschou SA, Andrikopoulou A, Mili N, Svarna A, Kaparelou M, Stefanaki K, et al. Possible prognostic role of BMI before chemotherapy in the outcomes of women with ovarian cancer. Nutrients. 2025;17:556. https:\/\/doi.org\/10.3390\/nu17030556.","journal-title":"Nutrients"},{"key":"1917_CR9","first-page":"5229","volume":"29","author":"L Delort","year":"2009","unstructured":"Delort L, Kwiatkowski F, Chalabi N, Satih S, Bignon Y-J, Bernard-Gallon DJ. Central adiposity as a major risk factor of ovarian cancer. Anticancer Res. 2009;29:5229\u201334.","journal-title":"Anticancer Res"},{"key":"1917_CR10","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EC Eugenia","year":"2003","unstructured":"Eugenia EC, Carmen R, Kimberly W-T, Michael JT. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The new England journal of medicine. N Engl J Med. 2003;348:1625\u201338. https:\/\/doi.org\/10.1056\/NEJMoa021423.","journal-title":"N Engl J Med"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41568-021-00388-4","volume":"21","author":"AJ Hoy","year":"2021","unstructured":"Hoy AJ, Nagarajan SR, Butler LM. Tumour fatty acid metabolism in the context of therapy resistance and obesity. Nat Rev Cancer. 2021;21:753\u201366. https:\/\/doi.org\/10.1038\/s41568-021-00388-4.","journal-title":"Nat Rev Cancer"},{"key":"1917_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/bjc.2017.162","volume":"117","author":"EV Bandera","year":"2017","unstructured":"Bandera EV, Lee VS, Qin B, Rodriguez-Rodriguez L, Powell CB, Kushi LH. Impact of body mass index on ovarian cancer survival varies by stage. Br J Cancer. 2017;117:282\u20139. https:\/\/doi.org\/10.1038\/bjc.2017.162.","journal-title":"Br J Cancer"},{"key":"1917_CR13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.5603\/GP.a2022.0035","volume":"93","author":"A Kukla","year":"2022","unstructured":"Kukla A, Piotrowska K, Misiek M, Chudecka-Glaz AM. Role of adipokines in ovarian cancer epidemiology and prognosis. Ginekol Pol. 2022;93:496\u2013500. https:\/\/doi.org\/10.5603\/GP.a2022.0035.","journal-title":"Ginekol Pol"},{"key":"1917_CR14","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/medicina61061025","volume":"61","author":"V Brza\u010dki","year":"2025","unstructured":"Brza\u010dki V, Ran\u010di\u0107 A, Te\u0161i\u0107 Rajkovi\u0107 S, Nagorni I, Stamenkovi\u0107 M, Stankovi\u0107 E, et al. The influence of metabolic syndrome on the development of Gastrointestinal malignant tumors-a review. Medicina. 2025;61:1025. https:\/\/doi.org\/10.3390\/medicina61061025.","journal-title":"Medicina"},{"key":"1917_CR15","doi-asserted-by":"publisher","unstructured":"Xianglin Z, Yushuai M, Lang W, Hao L, Jie Z, Shijun Z, et al. Global burden of cancer attributable to high BMI (1990\u20132031): A multidimensional analysis based on GBD and Mendelian randomization. Frontiers in nutrition. Front Nutr. 2025;12. https:\/\/doi.org\/10.3389\/fnut.2025.1618799.","DOI":"10.3389\/fnut.2025.1618799"},{"key":"1917_CR16","doi-asserted-by":"publisher","unstructured":"Guang C, Shichen Z, Qiaoxin S, Yunqing X, Tung-Leong F, Ruogu X, et al. Global, regional, and National estimates of burden and risk factors of female cancers in child-bearing age: A systematic analysis for global burden of disease study and bayesian projection to 2030. Translational Oncol Transl Oncol. 2025;60. https:\/\/doi.org\/10.1016\/j.tranon.2025.102473.","DOI":"10.1016\/j.tranon.2025.102473"},{"key":"1917_CR17","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1186\/s12889-025-22881-3","volume":"25","author":"W-Z Tang","year":"2025","unstructured":"Tang W-Z, Cai Q-Y, Huang K-J, Xu W-Z, Li J-Z, Pan Y-R, et al. The global burden of polycystic ovary syndrome, endometriosis, uterine fibroids, cervical cancer, uterine cancer, and ovarian cancer from 1990 to 2021. BMC Public Health. 2025;25:1774. https:\/\/doi.org\/10.1186\/s12889-025-22881-3.","journal-title":"BMC Public Health"},{"key":"1917_CR18","doi-asserted-by":"publisher","unstructured":"Paula Portal T, Yvonne Yiru X, Aleksander A, Peng Z, Lisa MF, Jonathan K, et al. A burden of proof study of the effects of exposure to high fasting plasma glucose on the risk of seven types of cancer. Scientific reports. Sci Rep. 2025;15. https:\/\/doi.org\/10.1038\/s41598-025-13045-9.","DOI":"10.1038\/s41598-025-13045-9"},{"key":"1917_CR19","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","volume":"403","author":"GBD 2021 Risk Factors Collaborators","year":"2024","unstructured":"GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990\u20132021: A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2162\u2013203. https:\/\/doi.org\/10.1016\/S0140-6736(24)00933-4.","journal-title":"Lancet"},{"key":"1917_CR20","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD 2021 Diseases and Injuries Collaborators","year":"2024","unstructured":"GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the global burden of disease study 2021. Lancet. 2024;403:2133\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(24)00757-8.","journal-title":"Lancet"},{"key":"1917_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000957","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang T, Li D, Cao X. The global, regional, and National burden of colorectal cancer attributable to smoking from 1990 to 2021: a population-based study. Eur J Cancer Prev. 2025. https:\/\/doi.org\/10.1097\/CEJ.0000000000000957.","journal-title":"Eur J Cancer Prev"},{"key":"1917_CR22","doi-asserted-by":"publisher","first-page":"103019","DOI":"10.1016\/j.pmedr.2025.103019","volume":"51","author":"S Wang","year":"2025","unstructured":"Wang S, Zhang T, Li D, Cao X. The global, regional and National burden of peptic ulcer disease attributable to smoking from 1990 to 2021: A population-based study. Prev Med Rep. 2025;51:103019. https:\/\/doi.org\/10.1016\/j.pmedr.2025.103019.","journal-title":"Prev Med Rep"},{"key":"1917_CR23","doi-asserted-by":"publisher","unstructured":"Zhou X-D, Chen Q-F, Yang W, Zuluaga M, Targher G, Byrne CD et al. Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021. eClinicalMedicine. Elsevier; 2024;76. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102848","DOI":"10.1016\/j.eclinm.2024.102848"},{"key":"1917_CR24","doi-asserted-by":"publisher","unstructured":"Huang M, Wang L, Lou Y, Qiu Z, Yu S, Xuan F. Temporal trends in cancer mortality attributable to high BMI in asia: an age-period-cohort analysis based on GBD 1992\u20132021. Front Endocrinol Front. 2025;16. https:\/\/doi.org\/10.3389\/fendo.2025.1691487.","DOI":"10.3389\/fendo.2025.1691487"},{"key":"1917_CR25","doi-asserted-by":"publisher","first-page":"102598","DOI":"10.1016\/j.arr.2024.102598","volume":"103","author":"Y Lu","year":"2025","unstructured":"Lu Y, Shang Z, Zhang W, Hu X, Shen R, Zhang K, et al. Global, regional, and National burden of spinal cord injury from 1990 to 2021 and projections for 2050: A systematic analysis for the global burden of disease 2021 study. Ageing Res Rev. 2025;103:102598. https:\/\/doi.org\/10.1016\/j.arr.2024.102598.","journal-title":"Ageing Res Rev"},{"key":"1917_CR26","doi-asserted-by":"publisher","first-page":"102875","DOI":"10.1016\/j.jiph.2025.102875","volume":"18","author":"A Zaino","year":"2025","unstructured":"Zaino A, Bonacquisti M, Russo L, Sabetta T, Solipaca A, Ricciardi W, et al. Influenza vaccination coverages in Italy from 1999\/00 to 2023\/24: A joinpoint regression analysis. J Infect Public Health. 2025;18:102875. https:\/\/doi.org\/10.1016\/j.jiph.2025.102875.","journal-title":"J Infect Public Health"},{"key":"1917_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2147\/RMHP.S506581","volume":"18","author":"Y Ma","year":"2025","unstructured":"Ma Y, Huang S, Dong Y, Jin Q. Global burden of alzheimer\u2019s disease attributable to high fasting plasma glucose: epidemiological trends and machine learning insights. Risk Manag Healthc Policy. 2025;18:1291\u2013307. https:\/\/doi.org\/10.2147\/RMHP.S506581.","journal-title":"Risk Manag Healthc Policy"},{"key":"1917_CR28","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3171\/2024.11.SPINE241048","volume":"42","author":"C Hejazi-Garcia","year":"2025","unstructured":"Hejazi-Garcia C, Howard SD, Quinones A, Malhotra NR, Yoon JW, Ozturk AK, et al. The social deprivation index and lumbar spine surgery outcomes. J Neurosurg Spine. 2025;42:579\u201388. https:\/\/doi.org\/10.3171\/2024.11.SPINE241048.","journal-title":"J Neurosurg Spine"},{"key":"1917_CR29","doi-asserted-by":"publisher","first-page":"e2024067900","DOI":"10.1542\/peds.2024-067900","volume":"155","author":"KC Bergus","year":"2025","unstructured":"Bergus KC, Bricker J, Asti L, Gorham TJ, Mansfield A, Srinivas S, et al. Social deprivation index and pediatric pedestrian-vs-automobile collisions in Ohio. Pediatrics. 2025;155:e2024067900. https:\/\/doi.org\/10.1542\/peds.2024-067900.","journal-title":"Pediatrics"},{"key":"1917_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","volume":"94","author":"Y Xie","year":"2018","unstructured":"Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the global burden of disease study highlights the global, regional, and National trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94:567\u201381. https:\/\/doi.org\/10.1016\/j.kint.2018.04.011.","journal-title":"Kidney Int"},{"key":"1917_CR31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.apmr.2018.08.179","volume":"100","author":"OT Hall","year":"2019","unstructured":"Hall OT, McGrath RP, Peterson MD, Chadd EH, DeVivo MJ, Heinemann AW, et al. The burden of traumatic spinal cord injury in the united states: Disability-adjusted life years. Arch Phys Med Rehabil. 2019;100:95\u2013100. https:\/\/doi.org\/10.1016\/j.apmr.2018.08.179.","journal-title":"Arch Phys Med Rehabil"},{"key":"1917_CR32","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1186\/s12889-025-22378-z","volume":"25","author":"W Liu","year":"2025","unstructured":"Liu W, Deng W, Gong X, Ou J, Yu S, Chen S. Global burden of alzheimer\u2019s disease and other dementias in adults aged 65 years and over, and health inequality related to SDI, 1990\u20132021: analysis of data from GBD 2021. BMC Public Health. 2025;25:1256. https:\/\/doi.org\/10.1186\/s12889-025-22378-z.","journal-title":"BMC Public Health"},{"key":"1917_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12884-025-07409-2","volume":"25","author":"Q Hu","year":"2025","unstructured":"Hu Q, Wang L, Chen Q, Wang Z. The global, regional, and National burdens of maternal sepsis and other maternal infections and trends from 1990 to 2021 and future trend predictions: results from the global burden of disease study 2021. BMC Pregnancy Childbirth. 2025;25:285. https:\/\/doi.org\/10.1186\/s12884-025-07409-2.","journal-title":"BMC Pregnancy Childbirth"},{"key":"1917_CR34","doi-asserted-by":"publisher","unstructured":"Yuan H, Yan B, Chong Y, Wang L, Yong J. Time trend of measles burden on children and adolescents in BRICS-plus countries from 1990 to 2021 and prediction to 2032. Frontiers in microbiology. Front Microbiol; 2025;16. https:\/\/doi.org\/10.3389\/fmicb.2025.1612124","DOI":"10.3389\/fmicb.2025.1612124"},{"key":"1917_CR35","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3934\/publichealth.2021048","volume":"8","author":"S Abolmaali","year":"2021","unstructured":"Abolmaali S, Shirzaei S. A comparative study of SIR model, linear regression, logistic function and ARIMA model for forecasting COVID-19 cases. AIMSPH. 2021;8:598\u2013613. https:\/\/doi.org\/10.3934\/publichealth.2021048.","journal-title":"AIMSPH"},{"key":"1917_CR36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ckj\/sfac218","volume":"16","author":"Y Li","year":"2023","unstructured":"Li Y, Ning Y, Shen B, Shi Y, Song N, Fang Y, et al. Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the global burden of disease study 2019. Clin Kidney J. 2023;16:312\u201321. https:\/\/doi.org\/10.1093\/ckj\/sfac218.","journal-title":"Clin Kidney J"},{"key":"1917_CR37","doi-asserted-by":"publisher","unstructured":"Ta I, Jd B, Ld B-G, Kl C, Jj C. KDOQI clinical practice guideline for nutrition in CKD: 2020 Update. American journal of kidney diseases: the official journal of the National kidney foundation. Am J Kidney Dis. 2020;76. https:\/\/doi.org\/10.1053\/j.ajkd.2020.05.006.","DOI":"10.1053\/j.ajkd.2020.05.006"},{"key":"1917_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12905-025-03904-y","volume":"25","author":"J Gui","year":"2025","unstructured":"Gui J. Analysis of global ovarian cancer disease burden and its changing trend from 1990 to 2021. BMC Womens Health. 2025;25:352. https:\/\/doi.org\/10.1186\/s12905-025-03904-y.","journal-title":"BMC Womens Health"},{"key":"1917_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-025-01660-y","volume":"18","author":"T Li","year":"2025","unstructured":"Li T, Zhang H, Lian M, He Q, Lv M, Zhai L, et al. Global status and attributable risk factors of breast, cervical, ovarian, and uterine cancers from 1990 to 2021. J Hematol Oncol. 2025;18:5. https:\/\/doi.org\/10.1186\/s13045-025-01660-y.","journal-title":"J Hematol Oncol"},{"key":"1917_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/CEJ.0000000000000899","volume":"34","author":"Q Zhuang","year":"2025","unstructured":"Zhuang Q, Gu G, Chen J, Tang Z, Wu C, Liu J, et al. Global, regional, and National burden of ovarian cancer among young women during 1990\u20132019. Eur J Cancer Prev. 2025;34:1\u201310. https:\/\/doi.org\/10.1097\/CEJ.0000000000000899.","journal-title":"Eur J Cancer Prev"},{"key":"1917_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s13046-023-02740-y","volume":"42","author":"Y Liu","year":"2023","unstructured":"Liu Y, Yang J, Hilliard TS, Wang Z, Johnson J, Wang W, et al. Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy. J Exp Clin Cancer Res. 2023;42:165. https:\/\/doi.org\/10.1186\/s13046-023-02740-y.","journal-title":"J Exp Clin Cancer Res"},{"key":"1917_CR42","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1186\/s12889-024-18858-3","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu Y, Shi W, Mubarik S, Wang F. Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis. BMC Public Health. 2024;24:1349. https:\/\/doi.org\/10.1186\/s12889-024-18858-3.","journal-title":"BMC Public Health"},{"key":"1917_CR43","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1002\/osp4.697","volume":"9","author":"AA Huang","year":"2023","unstructured":"Huang AA, Huang SY. Stochastic modeling of obesity status in united States adults using Markov chains: A nationally representative analysis of population health data from 2017\u20132020. Obes Sci Pract. 2023;9:653\u201360. https:\/\/doi.org\/10.1002\/osp4.697.","journal-title":"Obes Sci Pract"},{"key":"1917_CR44","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NH Phelps","year":"2024","unstructured":"Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE, et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet Elsevier. 2024;403:1027\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(23)02750-2.","journal-title":"Lancet Elsevier"},{"key":"1917_CR45","unstructured":"Global Health Expenditure Database. https:\/\/apps.who.int\/nha\/database\/Search\/Index\/en?q=+United+States"},{"key":"1917_CR46","unstructured":"CiNA. https:\/\/www.naaccr.org\/cina\/"},{"key":"1917_CR47","unstructured":"World Bank Open Data. World Bank Open Data. https:\/\/data.worldbank.org"},{"key":"1917_CR48","unstructured":"Contraceptive Use in the United States by Demographics | Guttmacher Institute. 2020. https:\/\/www.guttmacher.org\/fact-sheet\/contraceptive-use-united-states. Accessed 26 Oct 2025."},{"key":"1917_CR49","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1186\/s12889-025-23303-0","volume":"25","author":"R Zhang","year":"2025","unstructured":"Zhang R, Zhao J, Du P, Fan S, Wang L, Wang L, et al. Global burden and trends in ovarian cancer attributable to environmental risks and occupational risks in females aged 20\u201349 from 1990 to 2021, with projections to 2050: A cross-sectional study. BMC Public Health. 2025;25:2547. https:\/\/doi.org\/10.1186\/s12889-025-23303-0.","journal-title":"BMC Public Health"},{"key":"1917_CR50","doi-asserted-by":"publisher","first-page":"e35712","DOI":"10.1002\/cncr.35712","volume":"131","author":"W Ren","year":"2025","unstructured":"Ren W, Guo X, Liu Z, Wu Y, Peng R, Liu H, et al. Burden of female-specific cancers in China from 1990 to 2021: A systematic analysis for the global burden of disease study 2021. Cancer. 2025;131:e35712. https:\/\/doi.org\/10.1002\/cncr.35712.","journal-title":"Cancer"},{"key":"1917_CR51","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1186\/s12889-022-13861-y","volume":"22","author":"S Zhang","year":"2022","unstructured":"Zhang S, Cheng C, Lin Z, Xiao L, Su X, Zheng L, et al. The global burden and associated factors of ovarian cancer in 1990\u20132019: findings from the global burden of disease study 2019. BMC Public Health. 2022;22:1455. https:\/\/doi.org\/10.1186\/s12889-022-13861-y.","journal-title":"BMC Public Health"},{"key":"1917_CR52","doi-asserted-by":"publisher","DOI":"10.1097\/CEJ.0000000000000978","author":"X Zhu","year":"2025","unstructured":"Zhu X, Xuan F, Yu S, Qiu Z, Lou Y, Qiu Z. Quantitative analysis of trends and inequalities in disease burden and care quality of gynecological cancers, 1990\u20132021. Eur J Cancer Prev. 2025. https:\/\/doi.org\/10.1097\/CEJ.0000000000000978.","journal-title":"Eur J Cancer Prev"},{"key":"1917_CR53","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ijc.32322","volume":"146","author":"CJ Cabasag","year":"2020","unstructured":"Cabasag CJ, Arnold M, Butler J, Inoue M, Trabert B, Webb PM, et al. The influence of birth cohort and calendar period on global trends in ovarian cancer incidence. Int J Cancer. 2020;146:749\u201358. https:\/\/doi.org\/10.1002\/ijc.32322.","journal-title":"Int J Cancer"},{"key":"1917_CR54","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/jnci\/djac004","volume":"114","author":"LH Schrijver","year":"2022","unstructured":"Schrijver LH, Mooij TM, Pijpe A, Sonke GS, Mourits MJE, Andrieu N, et al. Oral contraceptive use in BRCA1 and BRCA2 mutation carriers: absolute cancer risks and benefits. J Natl Cancer Inst. 2022;114:540\u201352. https:\/\/doi.org\/10.1093\/jnci\/djac004.","journal-title":"J Natl Cancer Inst"},{"key":"1917_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ygyno.2022.10.018","volume":"168","author":"MT Phung","year":"2023","unstructured":"Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DDL, et al. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecol Oncol. 2023;168:68\u201375. https:\/\/doi.org\/10.1016\/j.ygyno.2022.10.018.","journal-title":"Gynecol Oncol"},{"key":"1917_CR56","doi-asserted-by":"publisher","unstructured":"Vercellini P, Buffo C, Vigan\u00f2 P, Somigliana E. Update on medical treatment of endometriosis: new drugs or new therapeutic approaches? Gynecol Obstet Invest. 2024;1\u201325. https:\/\/doi.org\/10.1159\/000542947.","DOI":"10.1159\/000542947"},{"key":"1917_CR57","unstructured":"Australian Institute of Health and Welfare. Cancer data in Australia. 2025. https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia. Accessed 25 Oct 2025."},{"key":"1917_CR58","unstructured":"World Health Rankings. Obesity prevalence in Australia & New Zealand 2021. World Life Expectancy. https:\/\/www.worldlifeexpectancy.com\/"},{"key":"1917_CR59","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1186\/s12885-023-10956-6","volume":"23","author":"LR Hallsson","year":"2023","unstructured":"Hallsson LR, Sroczynski G, Engel J, Siebert U. Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1\/2 mutations. BMC Cancer. 2023;23:590. https:\/\/doi.org\/10.1186\/s12885-023-10956-6.","journal-title":"BMC Cancer"},{"key":"1917_CR60","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000521840","volume":"15","author":"P Godin","year":"2022","unstructured":"Godin P, Duhoux FP, Mazzeo F, Rojas M, Bollue E, Fran\u00e7ois A, et al. BRCA1 mutation:an insidious enemy with multiple facets\u2026. Case Rep Oncol. 2022;15:238\u201344. https:\/\/doi.org\/10.1159\/000521840.","journal-title":"Case Rep Oncol"},{"key":"1917_CR61","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3390\/cancers14092230","volume":"14","author":"J Huang","year":"2022","unstructured":"Huang J, Chan WC, Ngai CH, Lok V, Zhang L, Lucero-Prisno DE, et al. Worldwide burden, risk factors, and Temporal trends of ovarian cancer: A global study. Cancers. 2022;14:2230. https:\/\/doi.org\/10.3390\/cancers14092230.","journal-title":"Cancers"},{"key":"1917_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","volume":"22","author":"AT Ali","year":"2023","unstructured":"Ali AT, Al-Ani O, Al-Ani F. Epidemiology and risk factors for ovarian cancer. Prz Menopauzalny. 2023;22:93\u2013104. https:\/\/doi.org\/10.5114\/pm.2023.128661.","journal-title":"Prz Menopauzalny"},{"key":"1917_CR63","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/antiox14070759","volume":"14","author":"U Urz\u00faa","year":"2025","unstructured":"Urz\u00faa U, Mar\u00edn A, Castell\u00f3n EA. Oxidative stress, parity history, and remnant follicles in the aged ovary: insights on ovarian cancer risk and protection. Antioxidants. 2025;14:759. https:\/\/doi.org\/10.3390\/antiox14070759.","journal-title":"Antioxidants"},{"key":"1917_CR64","doi-asserted-by":"publisher","first-page":"e936","DOI":"10.1002\/hsr2.936","volume":"5","author":"A Mazidimoradi","year":"2022","unstructured":"Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, et al. The global, regional and National epidemiology, incidence, mortality, and burden of ovarian cancer. Health Sci Rep. 2022;5:e936. https:\/\/doi.org\/10.1002\/hsr2.936.","journal-title":"Health Sci Rep"},{"key":"1917_CR65","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/diagnostics11010084","volume":"11","author":"ML Hutchcraft","year":"2021","unstructured":"Hutchcraft ML, Gallion HH, Kolesar JM. MUTYH as an emerging predictive biomarker in ovarian cancer. Diagnostics. 2021;11:84. https:\/\/doi.org\/10.3390\/diagnostics11010084.","journal-title":"Diagnostics"},{"key":"1917_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5935\/1518-0557.20210067","volume":"26","author":"N Khanlarkhani","year":"2022","unstructured":"Khanlarkhani N, Azizi E, Amidi F, Khodarahmian M, Salehi E, Pazhohan A, et al. Metabolic risk factors of ovarian cancer: A review. JBRA Assist Reprod. 2022;26:335\u201347. https:\/\/doi.org\/10.5935\/1518-0557.20210067.","journal-title":"JBRA Assist Reprod"},{"key":"1917_CR67","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.3892\/or.2020.7548","volume":"43","author":"L Wang","year":"2020","unstructured":"Wang L, Li X. Identification of an energy metabolism\u2013related gene signature in ovarian cancer prognosis. Oncol Rep. 2020;43:1755\u201370. https:\/\/doi.org\/10.3892\/or.2020.7548.","journal-title":"Oncol Rep"},{"key":"1917_CR68","doi-asserted-by":"publisher","first-page":"682461","DOI":"10.3389\/fonc.2021.682461","volume":"11","author":"R Gou","year":"2021","unstructured":"Gou R, Hu Y, Liu O, Dong H, Gao L, Wang S, et al. PGK1 is a key target for anti-glycolytic therapy of ovarian cancer: based on the comprehensive analysis of glycolysis-related genes. Front Oncol. 2021;11:682461. https:\/\/doi.org\/10.3389\/fonc.2021.682461.","journal-title":"Front Oncol"},{"key":"1917_CR69","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12889-025-21428-w","volume":"25","author":"P Huang","year":"2025","unstructured":"Huang P, Zhang J. Global leukemia burden and trends: A comprehensive analysis of Temporal and Spatial variations from 1990\u20132021 using GBD (global burden of disease) data. BMC Public Health. 2025;25:262. https:\/\/doi.org\/10.1186\/s12889-025-21428-w.","journal-title":"BMC Public Health"},{"key":"1917_CR70","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12882-025-04386-8","volume":"26","author":"Y He","year":"2025","unstructured":"He Y, Tang W, Chen J, Tang J, Zheng Y, Wang X, et al. Global burden of chronic kidney disease due to hypertension (1990\u20132021): A systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study. BMC Nephrol. 2025;26:448. https:\/\/doi.org\/10.1186\/s12882-025-04386-8.","journal-title":"BMC Nephrol"},{"key":"1917_CR71","doi-asserted-by":"publisher","unstructured":"R Z, J Z, P D, S F, L W, Y F. Global burden and trends in ovarian cancer attributable to environmental risks and occupational risks in females aged 20\u201349 from 1990 to 2021, with projections to 2050: A cross-sectional study. BMC public health. BMC Public Health; 2025;25. https:\/\/doi.org\/10.1186\/s12889-025-23303-0","DOI":"10.1186\/s12889-025-23303-0"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01917-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01917-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01917-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:36:57Z","timestamp":1769603817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01917-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01917-7","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the study was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"31"}}